Noninvasix

Noninvasix is a private medical technology company developing a noninvasive monitoring system for central venous oxygen saturation, a hemodynamic marker relevant to sepsis, septic shock, and tissue hypoxia. Its core product, the LIVOx Central Venous Oxygenation Monitor, uses a patented optoacoustic platform intended to continuously assess venous oxygenation without invasive catheterization. The company positions the technology for use in intensive care workflows to help clinicians diagnose and monitor critically ill patients earlier and more safely. Noninvasix was founded from work at the University of Texas Medical Branch and has received both grant and venture backing. As of the latest publicly available company materials, its technology is not yet FDA approved and is not commercially available in the United States.